Latest Conference Articles

Fewer ocular symptoms linked to e-cigarettes than traditional cigarettes

Fewer ocular symptoms linked to e-cigarettes than traditional cigarettes

October 3rd 2022

AAO

Those who used both traditional and electronic cigarettes reported severe to very severe ophthalmic symptoms.

Faricimab for nAMD: Safe, effective, lower treatment burden compared with aflibercept in pooled TENAYA, LUCERNE Phase 3 trials

Faricimab for nAMD: Safe, effective, lower treatment burden compared with aflibercept in pooled TENAYA, LUCERNE Phase 3 trials

October 2nd 2022

AAO

The AVONELLE-X long-term extension study will continue to evaluate the efficacy, durability, and safety of faricimab in patients with neovascular AMD.

Late-breaking: Janssen announces data from 2 gene therapy programs

Late-breaking: Janssen announces data from 2 gene therapy programs

October 2nd 2022

AAO

Janssen noted that results from Phase 1/2 MGT009 study demonstrate safety profile of investigational gene therapy botaretigene sparoparvovec (AAV-RPGR) and suggest sustained vision improvement in patients with X-linked retinitis pigmentosa.

Acute retinal necrosis: Retinal detachment rates are unaffected by early treatment with intravitreal antivirals, vitrectomy

Acute retinal necrosis: Retinal detachment rates are unaffected by early treatment with intravitreal antivirals, vitrectomy

October 2nd 2022

AAO

The results also showed that, compared to use of systemic antivirals alone, treatment with adjunctive intravitreal injections or early pars plana vitrectomy did not affect the time to development of retinal detachments.

Understanding fluid dynamics in wet macular degeneration

Understanding fluid dynamics in wet macular degeneration

October 1st 2022

AAO

At AAO 2022, Justis Ehlers, MD, presented a talk entitled, "Defining the Fluid Problem in Neovascular AMD: To Dry or Not to Dry?"

IRIS Registry: Comparing dry eye disease in adult and pediatric populations

IRIS Registry: Comparing dry eye disease in adult and pediatric populations

October 1st 2022

AAO

Almost 5 million patients in the IRIS Registry had received at least one diagnosis of DED between 2013 and 2019; of those, 203,171 were children under 18 years of age and 4,592,808 were adults.

Continuous range-of-motion IOL scores high in patient satisfaction

Continuous range-of-motion IOL scores high in patient satisfaction

September 30th 2022

AAO

Investigators reported that the safety and efficacy of the Tecnis Synergy IOL model ZFR00V indicates that it may be a good option for patients who desire meaningful gains in uncorrected visual acuity at all distances.

Pediatric patients have higher incidence of new strabismus following tube shunt surgery than adult patients

Pediatric patients have higher incidence of new strabismus following tube shunt surgery than adult patients

September 30th 2022

AAO

13% of pediatric patients had new-onset strabismus after a tube shunt procedure; in contrast, 0% of adults had new-onset strabismus after tube shunt surgery (at 6 months or at last follow-up).

YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME

YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME

September 30th 2022

AAO

Roger A. Goldberg, MD, MBA, discusses his 2022 AAO poster: "T&E-Based Personalized Treatment Interval Dynamics in the YOSEMITE/RHINE Trials of Faricimab in DME."

Poll results: Do you plan to attend the 2022 AAO Meeting?

Poll results: Do you plan to attend the 2022 AAO Meeting?

September 29th 2022

AAO

Results from our recent poll regarding AAO 2022 attendance indicate that most ophthalmologists and retina specialists plan to participate in the Annual Meeting in person in Chicago, Illinois.